Download PDF
Thromb Haemost 1967; 18(01/02): 001-011
DOI: 10.1055/s-0038-1655012
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Hemostasis as an Evolutionary Development[*]

A. J Quick Professor Emeritus of Biochemistry
1   Marquette University School of Medicine, Milwaukee, Wisconsin 53233
› Author Affiliations
Further Information

Publication History

Publication Date:
26 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

Hemostasis is a complex physiological mechanism that has evolved as the organism increased in complexity and the need for safeguarding against loss of blood became progressively greater. The most primitive phase is vascular contraction which sufficed until the cardiovascular system made greater demands on the need for protection against hemorrhage. The developing of a coalescing blood cell constituted the second major advance in the mechanism of hemostasis, and it is very probable that the thrombocytes of avian and reptile blood and the platelets of mammalian blood represent the evolutionary end products of this phase. The clotting mechanism is the last step and is the third line defense against hemorrhage. Even in the higher forms of life including man, none of these steps in hemostasis have been supplanted, but rather have been supplemented. Therefore residua of the primary step are not only present but still functioning. To understand the problem of bleeding, it must be viewed from the global aspect of hemostasis.

* The work was supported by a grant from the National Heart Institute, National Institute of Health, U.S. Public Health Service.


 

  • References

  • 1 Bettex-Galland M, Lüscher E. F. Extraction of an actomyosin-like protein from human erythrocytes. Nature (Lond) 184: 276 1959;
    PubMedGoogle Scholar
  • 2 Biggs R, Douglas A. S. The thromboplastin generation test. J. clin. Path. 06: 23 1953;
    CrossrefPubMedGoogle Scholar
  • 3 Biggs and Macfarlane: The Treatment of Haemophilia and other Coagulation Disorders. F. A. Davis Co; Philadelphia: 1966
    Google Scholar
  • 4 Chevallier P. Sur les irrégularités minimes du temps de saignement. Sang. 17: 511 1946;
    PubMedGoogle Scholar
  • 4a Duckert F, Jung E, Shmerling D. H. A hitherto undescribed congenital haemorrhagic diathesis due to fibrin stabilizing factor deficiency. Thrombos. Diathes. haemorrh. (Stuttg) 05: 179 1960;
    PubMedGoogle Scholar
  • 5 Duke W. W. The relation of blood platelets to hemorrhagic disease: Description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion. J. Amer. med. Ass. 55: 1185 1910;
    CrossrefPubMedGoogle Scholar
  • 6 Friedman I. A, Quick A. J, Higgins F, Hussey G. V, Hickey M. E. Hereditary labile factor (factor V) deficiency. J. Amer. med. Ass. 175: 370 1961;
    CrossrefPubMedGoogle Scholar
  • 7 Hellem A. J. The influence of adenosine diphosphate on platelet adhesiveness, Symposium on Biol. Aspects of Occlusive Vascular Disease. Cambridge. 1962
    PubMedGoogle Scholar
  • 8 König L. Versuche über Blutstillung. Klin. Wschr. 01: 2376 1922;
    CrossrefPubMedGoogle Scholar
  • 9 Minot G. R. A familial hemorrhagic condition with prolongation of the bleeding time. Amer. J. med. Sci. 175: 301 1928;
    CrossrefPubMedGoogle Scholar
  • 10 Morand S. F. Mem. d. Acad. roy. de chirurgie V Ed. 8 1736;
    PubMedGoogle Scholar
  • 11 Morawitz P. Beiträge zur Kenntnis der Blutgerinnung. Beitr. chem. Physiol. Path. 05: 133 1904;
    PubMedGoogle Scholar
  • 12 Page I. H. Serotonin (5 hydroxytryptamine), Physiol. Rev. 34: 563 1954;
    PubMedGoogle Scholar
  • 13 Petit J. E. Mem. de l’Acad. Roy. des Sci.,. 1731; 90 and Hist. de l’Acad. Roy. des Sci., (1735) p. 14.
    PubMedGoogle Scholar
  • 14 Quick A. J. The normal antithrombin of the blood and its relation to heparin, Amer. J. Physiol. 123: 712 1938;
    PubMedGoogle Scholar
  • 15 Quick A. J. The Hemorrhagic Diseases and the Physiology of Hemostasis. C. C. Thomas; Springfield, Illinois: 1942
    Google Scholar
  • 16 Quick A. J. Studies on the enigma of the hemostatic dysfunction of hemophilia. Amer. J. med. Sci. 214: 272 1947;
    CrossrefPubMedGoogle Scholar
  • 17 Quick A. J. Congenital hypoprothrombinaemia and pseudo-hypoprothrombinaemia. Lancet. II: 379 1947;
    PubMedGoogle Scholar
  • 18 Quick A. J. The determinant of the prothrombin time in normal human plasma. Thrombos. Diathes. haemorrh. (Stuttg) 02: 226 1958;
    PubMedGoogle Scholar
  • 19 Quick A. J. Hemolysate prothrombin consumption time: A new test for thromboplastino-genic coagulation defects. J. Lab. and clin. Med. 57: 290 1961;
    PubMedGoogle Scholar
  • 20 Quick A. J. Mild hemophilia A: Probability of a variant. Amer. J. med. Sci. 244: 535 1962;
    PubMedGoogle Scholar
  • 21 Quick A. J. One-stage prothrombin time in the control of anticoagulant therapy, Anticoagulant Therapy in Ischemic Heart Disease, An International Symposium sponsored by the Miami Heart Institute. 1964: 381-388 E. Sterling Nichol; Editor 1965
    Google Scholar
  • 22 Quick A. J. Effect of aspirin on the bleeding time. Fed. Proc. 25: 498 1966;
    PubMedGoogle Scholar
  • 23 Quick A. J. Thrombopathy-thrombasthenia. Amer. J. med. Sci. 251: 156 1966;
    CrossrefPubMedGoogle Scholar
  • 24 Quick A. J. Current blood clotting schemes. Thrombos. Diathes. haemorrh. (Stuttg) 16: 318 1966;
    PubMedGoogle Scholar
  • 25 Quick A. J. Menstruation in hereditary bleeding disorders. Obstet. Gynecol 28: 37 1966;
    PubMedGoogle Scholar
  • 26 Quick A. J. Hemorrhagic Diseases and Thrombosis. Lea Febiger. (1957) 1966
    PubMedGoogle Scholar
  • 27 Quick A. J. Salicylates and bleeding: The aspirin tolerance test. Amer. J. med. Sci. 252: 265 1966;
    CrossrefPubMedGoogle Scholar
  • 28 Quick A. J. The prothrombin concentration in the blood of various species. Amer. J. Physiol. 132: 239 1941;
    PubMedGoogle Scholar
  • 29 Quick A. J. The Duke bleeding time. Amer. J. clin. Path. (In press.)
    PubMedGoogle Scholar
  • 30 Quick A. J. The Minot von Willebrand syndrome. J. Lab. clin. Med. 68: 1008 1966;
    PubMedGoogle Scholar
  • 31 Quick A. J, Georgatsos J. G, Hussey G. V. The clotting activity of human erythrocytes: Theoretical and clinical implications. Amer. J. med. Sci. 228: 207 1954;
    CrossrefPubMedGoogle Scholar
  • 32 Quick A. J, Hussey G. V. Hemophilia: Quantitative studies of the coagulation defect. Amer. med. Ass. Arch. Intern. Med. 97: 524 1956;
    PubMedGoogle Scholar
  • 33 Quick A. J, Hussey G. V. Hyperheparinemia: Report of a case. Amer. J. med. Sci. 234: 251 1957;
    PubMedGoogle Scholar
  • 34 Quick A. J, Hussey C. V. Hereditary hypoprothrombinaemias. Lancet. I: 173 1962;
    PubMedGoogle Scholar
  • 35 Quick A. J, Hussey G. V. Hereditary thrombopathic thrombocytopenia. Amer. J. med. Sci. 245: 643 1963;
    PubMedGoogle Scholar
  • 36 Quick A. J, Hussey G. V, Harris J, Peters K. Occult intravascular clotting by means of intravenous injection of thrombin. Amer. J. Physiol. 197: 791 1959;
    PubMedGoogle Scholar
  • 37 Quick A. J, Ota R. K, Baronofsky I. D. On the thrombopenia of anaphylactic and peptone shock. Amer. J. Physiol. 145: 273 1946;
    PubMedGoogle Scholar
  • 38 Quick A. J, Shanberge J. N, Stefanini M. The role of platelets in the coagulation of the blood. Amer. J. med. Sci. 217: 198 1949;
    CrossrefPubMedGoogle Scholar
  • 39 Roskam J. The hemostatic paradox and its present problem. Thrombos. Diathes. haemorrh. (Stuttg) 14: 626 1965;
    PubMedGoogle Scholar
  • 40 Sherry S, Fletcher A. P, Alkjaersig N. Fibrinolysis and fibrinolytic activity in man. Physiol. Rev. 39: 343 1959;
    CrossrefPubMedGoogle Scholar
  • 41 von Willebrand E. A. Über hereditäre Pseudohämophilie. Acta med. scand. 76: 521 1931;
    PubMedGoogle Scholar
  • 42 Wright A. D. On a method of determining the condition of blood coagulability for clinical and experimental purposes and on the effect of the administration of calcium salts in haemophilia and actual or threatened haemorrhage. Brit. med. J. II: 223 1893;
    PubMedGoogle Scholar
  • 43 Zucker M. B, Borrelli J. Quantity, assay and release of serotonin in human platelets. J. appl. Physiol. 7: 425 (1955); Relationship of some blood clotting factors to serotonin release from washed platelets. ibid. 07: 432 1955;
    PubMedGoogle Scholar